President Tsai Ing-wen (蔡英文) yesterday said that she would get inoculated with the COVID-19 vaccine manufactured by Taiwan-based Medigen Vaccine Biologics Corp (高端疫苗).
Tsai wrote on Facebook that she had registered for her first vaccine dose using the national online COVID-19 vaccination booking system, which allows people to indicate their preferred vaccine brand and to make an appointment when the shot becomes available.
Tsai said that she opted for the Medigen vaccine — one of three now available on the system, along with the AstraZeneca and Moderna vaccines — even though Medigen has yet to deliver any doses or provide a delivery schedule.
Photo: Peter Lo, Taipei Times
“The government will only supply vaccines that are safe, effective, legitimate and in line with scientific standards,” Tsai said, in a gesture of support for the Medigen vaccine.
The Food and Drug Administration last week granted the Medigen vaccine emergency use authorization (EUA), even though the drugmaker has yet to complete phase 3 clinical trials.
Approval was given because the neutralizing antibodies generated in Medigen vaccine recipients compared favorably with those generated in AstraZeneca recipients, a concept known as immunobridging.
The concept has been discussed internationally, but no consensus or standard has been reached regarding its use. Taiwan is the first country to use it for vaccine approvals.
The government has contracted to purchase 5 million doses of the Medigen vaccine.
People aged 20 or older can be inoculated with the vaccine, which requires two doses administered 28 days apart.
Presidential Office spokesman Xavier Chang (張惇涵) said that Vice President William Lai (賴清德) plans to get inoculated with the vaccine of another domestic company, United Biomedical Inc (聯亞生技).
The FDA has yet to approve an EUA for the United Biomedical vaccine. The drugmaker presented the data from its phase 2 clinical trials and submitted an EUA application to the FDA at the end of last month, hoping to follow on Medigen’s coattails, but this week the FDA said that it must submit additional documentation before a review can begin.
Separately yesterday, a number of Democratic Progressive Party (DPP) lawmakers said that they had signed up to receive the Medigen vaccine.
Among them was Legislator Kao Chia-yu (高嘉瑜), who said that she canceled her registration for an AstraZeneca shot as soon as she heard that Medigen was available.
She would wait for a Medigen shot, because she wanted to support the nation’s biotech industry, Kao said, adding that the vaccine has the fewest side effects and is the safest option, although efficacy information would not be available until the phase 3 trials are done.
DPP Legislator Tsai Yi-yu (蔡易餘) said that he jumped at the opportunity to register for Medigen when the new registration period opened on Tuesday.
As long as a vaccine is effective, it is a good option, he said, expressing the hope that everyone would stand united on the matter.
DPP Legislator Tsai Shih-ying (蔡適應) said he also signed up on Tuesday, selecting Medigen as his only choice.
The successful development of a vaccine is not simply a corporate achievement, but holds strategic significance for the nation’s security, he added.
Across the aisle, Chinese Nationalist Party (KMT) Legislator Lin Wei-chou (林為洲) also announced that he had registered for the Medigen vaccine, based on the need for Taiwan to have its own vaccine industry.
However, as a member of the opposition party, Lin said that he must also criticize a lack of oversight in the approval process, as vaccines must be safe and effective.
By accepting Medigen, it leaves more doses of the international vaccines for the public, Lin said, calling on his colleagues to follow suit.
Additional reporting by Chien Hui-ju and Lin Liang-sheng
EUROPEAN TARGETS: The planned Munich center would support TSMC’s European customers to design high-performance, energy-efficient chips, an executive said Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest contract chipmaker, yesterday said that it plans to launch a new research-and-development (R&D) center in Munich, Germany, next quarter to assist customers with chip design. TSMC Europe president Paul de Bot made the announcement during a technology symposium in Amsterdam on Tuesday, the chipmaker said. The new Munich center would be the firm’s first chip designing center in Europe, it said. The chipmaker has set up a major R&D center at its base of operations in Hsinchu and plans to create a new one in the US to provide services for major US customers,
‘ABUSE OF POWER’: Lee Chun-yi allegedly used a Control Yuan vehicle to transport his dog to a pet grooming salon and take his wife to restaurants, media reports said Control Yuan Secretary-General Lee Chun-yi (李俊俋) resigned on Sunday night, admitting that he had misused a government vehicle, as reported by the media. Control Yuan Vice President Lee Hung-chun (李鴻鈞) yesterday apologized to the public over the issue. The watchdog body would follow up on similar accusations made by the Chinese Nationalist Party (KMT) and would investigate the alleged misuse of government vehicles by three other Control Yuan members: Su Li-chiung (蘇麗瓊), Lin Yu-jung (林郁容) and Wang Jung-chang (王榮璋), Lee Hung-chun said. Lee Chun-yi in a statement apologized for using a Control Yuan vehicle to transport his dog to a
BEIJING’S ‘PAWN’: ‘We, as Chinese, should never forget our roots, history, culture,’ Want Want Holdings general manager Tsai Wang-ting said at a summit in China The Mainland Affairs Council (MAC) yesterday condemned Want Want China Times Media Group (旺旺中時媒體集團) for making comments at the Cross-Strait Chinese Culture Summit that it said have damaged Taiwan’s sovereignty, adding that it would investigate if the group had colluded with China in the matter and contravened cross-strait regulations. The council issued a statement after Want Want Holdings (旺旺集團有限公司) general manager Tsai Wang-ting (蔡旺庭), the third son of the group’s founder, Tsai Eng-meng (蔡衍明), said at the summit last week that the group originated in “Chinese Taiwan,” and has developed and prospered in “the motherland.” “We, as Chinese, should never
‘A SURVIVAL QUESTION’: US officials have been urging the opposition KMT and TPP not to block defense spending, especially the special defense budget, an official said The US plans to ramp up weapons sales to Taiwan to a level exceeding US President Donald Trump’s first term as part of an effort to deter China as it intensifies military pressure on the nation, two US officials said on condition of anonymity. If US arms sales do accelerate, it could ease worries about the extent of Trump’s commitment to Taiwan. It would also add new friction to the tense US-China relationship. The officials said they expect US approvals for weapons sales to Taiwan over the next four years to surpass those in Trump’s first term, with one of them saying
RSS